Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy
<p>Abstract</p> <p>Background</p> <p>Adrenomyeloneuropathy (AMN) is one of several phenotypes of the adrenoleukodystrophy spectrum caused by mutations in the <it>ABCD1</it> gene on the X chromosome. An inflammatory component is part of the disease complex ra...
Main Authors: | Jønch Aia, Danielsen Else, Thomsen Carsten, Meden Per, Svenstrup Kirsten, Nielsen Jørgen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-09-01
|
Series: | BMC Neurology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2377/12/108 |
Similar Items
-
Adrenomyeloneuropathy (AMN): myelinopathy or axonopathy?
by: Herbert Budka
Published: (2023-12-01) -
Adrenomyeloneuropathy with bulbar palsy: A rare association
by: Vishal Annaji Chafale, et al.
Published: (2014-01-01) -
Adrenoleukodystrophy/Adrenomyeloneuropathy and Neurogenic Bladder Dysfunction. A Review
by: Khudyakova, N.V., et al.
Published: (2023-10-01) -
MicroRNA and metabolomics signatures for adrenomyeloneuropathy disease severity
by: Bela Rui Turk, et al.
Published: (2022-11-01) -
Considering the myelin-centric hypothesis: insights from Budka's historical adrenomyeloneuropathy case report
by: ETTORE SALSANO, et al.
Published: (2023-12-01)